Arid4a通过通过mRNA稳定性增强MTSS1表达来抑制乳腺瘤转移
Pengfei Wan1, Dandan Zhang1, Xueting Liu2
1Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Cancer medicine
|March 11, 2025
概括
富含AT的交互域含蛋白4A (Arid4a) 通过稳定转移抑制基因来抑制乳腺瘤转移. 这种RNA结合蛋白是RNA结合蛋白.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因规则 基因规则
背景情况:
- 瘤转移是癌症死亡的主要原因.
- 调节转移的机制,特别是RNA结合蛋白的转录后控制,如AT丰富的交互域含蛋白4A (Arid4a),仍然不清楚.
研究的目的:
- 为了研究Arid4a在乳腺瘤转移中的作用.
- 阐明Arid4a调节转移相关基因的分子机制.
主要方法:
- 使用生物信息分析,qRT-PCR,免疫组织化学和免疫血栓检测来评估乳腺瘤中的Arid4a表达.
- 在体外和体内实验中评估了Arid4a在转移中的功能作用.
- RNA免疫沉 (RIP),mRNA稳定性测试和RIP-ChIP阐明了Arid4a的作用机制.
主要成果:
- 在乳腺瘤中观察到Arid4a表达的减少,与患者预后不佳相关.
- Arid4a在体外和体内都显示出对瘤转移的抑制作用.
- Arid4a通过结合它们的3' UTRs来稳定转移抑制转录 (例如,MTSS1,TIMP2,Rb1,PTEN),其Arid域对此功能至关重要.
结论:
- Arid4a通过稳定转移抑制基因转录来抑制乳腺瘤转移.
- 在乳腺癌治疗中,Arid4a是潜在的治疗点.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


